Yaz, Other Birth Control Drugs Boost Blood Clot Risk: FDA
Women who took DRSP drugs were about 75 percent more likely to suffer from potentially fatal venous thromboembolism and similar conditions, the FDA said.
The announcement came in an update to the FDA’s ongoing study on the connection between blood clots and birth control drugs. The agency...
To view the full article, register now.